Triclonics™ ENGAGE: Trispecific Antibody Platform for Tumor Specific T-Cell Engagers

Time: 11:25 am
day: Day One

Details:

• Identify targets for Triclonics antibodies
• Explore therapeutic opportunities of trispecific T-cell engagers
• Overcome T-cell engager toxicities

Speakers: